The global blood collection market was valued at USD 7.4 billion in 2024 and is projected to reach USD 14.6 billion by the end of 2035, expanding at a CAGR of 6.4% from 2025 to 2035. Market growth is driven by the rising demand for diagnostic testing, the increasing prevalence of chronic and infectious diseases, and the growing need for safe and efficient blood collection procedures in healthcare facilities. Additionally, advancements in blood collection technologies, expanding healthcare infrastructure, and increasing awareness about regular health screening are expected to support the market’s growth during the forecast period.

👉 Get sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=33059

Market Overview

Blood collection is a fundamental step in clinical diagnostics, transfusion medicine, and genomic research. The market encompasses a vast array of consumables—such as vacuum tubes (vacutainers), needles, and blood bags—as well as specialized monitors and automated systems.

In 2026, the industry is increasingly defined by the shift from manual draws to automated collection and processing. This shift is particularly evident in high-throughput settings like blood banks and diagnostic laboratories, where precision and donor safety are paramount. Furthermore, the rise of liquid biopsy and personalized genomics has necessitated the development of advanced collection tubes with specialized additives to preserve cell-free DNA and RNA integrity.

Analysts’ Viewpoint on the Global Blood Collection Market

Analysts observe that the “Diagnostic Load” on healthcare systems is reaching a historical peak. With an aging global population and the rising prevalence of metabolic disorders like diabetes, the volume of routine blood draws is increasing by 5% to 7% annually.

A critical trend noted by researchers is the expansion of Point-of-Care (PoC) and home-based micro-sampling. Technologies that allow for capillary blood collection via painless lancets or vacuum-assisted patches are moving out of the “niche” category and into the mainstream, especially for pediatric and geriatric care. This trend is effectively decentralizing blood collection, moving it from the hospital ward to the patient’s home.

Analysis of Key Players in the Blood Collection Market

The market is characterized by a high degree of consolidation among a few global leaders who control the majority of the intellectual property regarding vacuum systems and safety needles.

Leading companies operating in the global market include:

• Abbott Laboratories
• Becton, Dickinson and Company
• Terumo Corp.
• Medtronic Plc
• Qiagen
• FL Medical s.r.l.
• Greiner Holding AG
• Haemonetics Corp.
• Sarstedt AG & Co.
• ICU Medical, Inc.
• CML Biotech
• SB-KAWASUMI LABORATORIES, INC.
• Mitra Industries Private Limited
• Other Prominent Players

These players are currently focusing on Safety-Engineered Devices (SEDs) to comply with stringent “Needlestick Prevention” laws in developed regions and are increasingly targeting emerging markets with cost-effective, high-volume production lines.

Recent Developments in the Blood Collection Market

• February 2026: A major new report on Blood Collection Needle Assembly Machines highlighted a massive surge in the adoption of fully automatic assembly lines, aimed at meeting the post-pandemic demand for high-traceability, zero-defect needles.
• January 2026: BD announced the expansion of its “Safety-Shield” needle portfolio, featuring dual-locking mechanisms designed specifically for high-risk infectious disease environments.
• May 2025: Terumo Blood and Cell Technologies opened a state-of-the-art production plant in Colorado, dedicated to manufacturing single-use kits for the newly FDA-approved Rika Plasma Donation System.

👉 Discuss Implications for Your Industry Request Sample Research Report PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33059

Key Market Trends & Strategies

🩸 The “Safety-First” Mandate

• Safety-Engineered Needles: Integration of retractable needles and protective shields is now standard in North America and Europe to prevent healthcare-associated infections (HAIs) and sharps injuries.
• Closed-System Collection: Growing preference for systems that eliminate blood exposure to the air, reducing contamination risks for both the sample and the technician.

📈 Market Challenges

• Phlebotomist Shortages: A global shortage of skilled phlebotomists is a primary bottleneck, leading to the rapid development of robotic blood-drawing systems.
• Environmental Impact: The industry is facing pressure to reduce the use of single-use plastics. Companies are now piloting eco-friendly, biodegradable collection tubes.

🌟 Growth Opportunities

• Liquid Biopsy Integration: Specialized tubes that stabilize circulating tumor cells (CTCs) are becoming a multi-billion dollar niche within the oncology sector.
• Micro-sampling Innovation: Devices that collect blood from the upper arm via microneedles are gaining traction in clinical trials and remote monitoring.

Market Segmentation

By Product Type

• Consumables (Tubes, Needles, Bags)
• Blood Collection Systems
• Lancets
• Monitors

By Method

• Manual Collection
• Automated Collection
• Capillary Micro-sampling
• Venous Access

By End-Use Setting

• Hospitals & Clinics
• Diagnostic & Pathology Labs
• Blood Banks
• Home-Care / Telehealth

Regional Outlook

• North America: Remains the dominant market (~35% share), driven by advanced diagnostic infrastructure and a high volume of surgical procedures.
• Asia-Pacific: The fastest-growing region (CAGR 8.2%+). China and India are experiencing a rapid demographic transition, with the geriatric population requiring frequent blood monitoring for chronic conditions.
• Europe: Strong emphasis on regulatory compliance (CE Marking) and the adoption of high-end automated plasma separation systems.

Conclusion

The blood collection market is evolving from a commodity-driven sector into a high-tech segment of the diagnostic ecosystem. Through 2035, growth will be defined by the “Three S’s”: Safety, Speed, and Simplification. As home-based healthcare becomes the new standard, the transition from painful venous draws to seamless, automated, and micro-volume collection will be the ultimate differentiator for market leaders.

👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=33059&ltype=S

Explore Latest Research Reports by Transparency Market Research:

Sleep Apnea Devices Market – https://www.transparencymarketresearch.com/sleep-apnea-devices-market.html

Medical Devices Outsourcing Market – https://www.transparencymarketresearch.com/medical-devices-outsourcing-market.html

Microscopy Devices Market – https://www.transparencymarketresearch.com/microscopy-market.html

Autoinjectors Market – https://www.transparencymarketresearch.com/autoinjectors-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered in Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trend analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants uses proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com